{"hero":{"image":"https://images.unsplash.com/photo-1559757148-5c350d0d3c56?w=1920&q=80","headline":"Evidence for Bone Marrow Concentrate","subheadline":"Studies up to 15–30 years show functional gains and delayed arthroplasty.","badge":"Clinical Research"},"whatToExpect":{"title":"What Studies Typically Report","steps":[{"icon":"clipboard-list","title":"Baseline Assessment","description":"Radiographic grading and pain/function scores (WOMAC, VAS) documented."},{"title":"Guided Injection","icon":"target","description":"Ultrasound or fluoroscopy-guided BMAC delivered intra-articularly or into subchondral bone."},{"description":"Pain and function reassessed; some studies follow patients to 15–30 years for arthroplasty-free survival.","title":"Follow-up 6–24+ Months","icon":"timeline"}],"variant":"timeline","enabled":true},"id":"bmac-therapy","faq":[{"answer":"Many cohorts report improvements through 12–24 months; long-term osteonecrosis data track patients for 15–30 years with reduced arthroplasty rates.","question":"How long do benefits last in studies?"},{"answer":"Protocols vary, but subchondral and intra-articular approaches are both reported, often combined with imaging guidance.","question":"Where is BMAC injected in trials?"},{"answer":"Published studies note low complication rates, primarily temporary post-procedure discomfort at the harvest or injection site.","question":"What are the main risks?"}],"shortTitle":"BMAC Evidence","seo":{"metaDescription":"Review randomized and long-term studies on bone marrow concentrate injections for knee osteoarthritis and osteonecrosis.","canonicalUrl":"/treatments/scientific-evidence/treatments/bmac-therapy","keywords":["BMAC knee osteoarthritis study","bone marrow concentrate evidence","stem cell osteonecrosis trial"],"h1":"BMAC Therapy: Clinical Evidence","metaTitle":"Scientific Evidence | Bone Marrow Aspirate Concentrate (BMAC)"},"description":"Randomized and long-term cohort studies evaluating bone marrow aspirate concentrate for knee osteoarthritis and osteonecrosis.","title":"Scientific Evidence for BMAC Therapy","cta":{"secondaryButton":"Call the clinic","primaryButton":"Book a consultation","title":"Considering BMAC Therapy?","subtitle":"We match study protocols to your imaging and goals."},"overview":{"content":"Subchondral and intra-articular BMAC injections have been compared with arthroplasty, exercise therapy, and placebo controls. Trials report meaningful WOMAC and VAS improvements, with several studies noting reduced progression to joint replacement at long-term follow-up.","highlights":["Randomized comparisons to arthroplasty and exercise therapy","Long-term cohorts (15–30 years) in osteonecrosis and OA","Endpoints: pain scores, function, arthroplasty-free survival"],"title":"What the Literature Shows","image":"https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1400&q=80"},"quickStats":{"sessions":"Single injection (booster optional)","duration":"Day procedure","downtime":"48-72 hrs","painLevel":"Low-Moderate","resultsLast":"3+ years","anesthesia":"Local + light sedation","resultsVisible":"8-12 weeks"},"benefits":{"title":"Evidence Highlights","features":[{"description":"Prospective studies show improved WOMAC and VAS compared with controls.","icon":"smile-plus","title":"Pain & function gains"},{"icon":"clock","title":"Delays surgery","description":"Randomized comparisons suggest lower conversion to arthroplasty in treated knees."},{"icon":"shield-check","title":"Favourable safety profile","description":"Adverse events are uncommon and typically limited to transient soreness."}]},"tagline":"Bone marrow concentrate for joint preservation and osteonecrosis","subcategoryId":"treatments","categoryId":"scientific-evidence","longDescription":"Prospective randomized studies compare BMAC injections to contralateral arthroplasty and exercise therapy, demonstrating improved pain and function with delayed need for replacement surgery. Fifteen to thirty-year follow-ups in osteonecrosis cohorts show sustained benefit and lower revision rates versus surgical controls.","howItWorks":{"background":"default","variant":"default","content":"BMAC delivers a high concentration of mesenchymal stem cells and signalling molecules harvested from the iliac crest. Injected into the joint or subchondral bone, they modulate inflammation, support cartilage repair, and may reinforce subchondral architecture to delay structural progression.","subtitle":"Concentrated MSCs, growth factors, and cytokines support cartilage and bone.","title":"Why Marrow-Derived Cells Matter","benefits":[{"description":"Marrow concentrate provides MSCs plus growth factors in a single procedure.","title":"High cell potency","icon":"cpu"},{"description":"Studies show targeted subchondral delivery can stabilise bone and cartilage.","icon":"shield","title":"Subchondral support"},{"description":"Long-term cohorts report extended arthroplasty-free survival.","icon":"calendar-range","title":"Durable outcomes"}],"enabled":true},"alternativeTitles":["Bone Marrow Concentrate Evidence","Marrow-Derived Cell Therapy Trials"]}